APSR2026-748

 
Late-Breaking
Submitted
Oral Presentation
AO31-005
 
 
https://storage.unitedwebnetwork.com/files/1285/1221187-46903-APSR-748_439572.pptx
Format: PPTX Only
 
Format: PDF Only
08. Lung Cancer
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Fia Afifah Mutiksa * University of Indonesia Department of Pulmonology and Respiratory Medicine / Faculty of Medicine Jakarta Indonesia
Ratnawati Ratnawati - University of Indonesia Department of Pulmonology and Respiratory Medicine / Faculty of Medicine Jakarta Indonesia
Hana Khairina Putri Faisal - University of Indonesia Department of Pulmonology and Respiratory Medicine / Faculty of Medicine Jakarta Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Fia Afifah
Mutiksa
mutiksa@gmail.com
+6282110053751
31-40
Indonesia
Original Research
Diffusing capacity of the lung for carbon monoxide and serum vascular endothelial growth factor levels as predictors of 6-month mortality in non-small cell lung cancer
Maximum 25 words
Abstract Content
Diffusing capacity of the lung for carbon monoxide (DLCO) representing a marker of lung damage and mostly intended for diffuse alterations of alveolo-capillary barrier. Vascular endothelial growth factor (VEGF) plays a central role in angiogenesis. The prognostic significance of VEGF levels in non-small cell lung cancer (NSCLC) remains controversial. This study aimed to investigate DLCO and serum VEGF levels as predictors of 6-month mortality in NSCLC patients.
All the newly diagnosed NSCLC patients based on histopathology underwent spirometry and DLCO test. Serum VEGF levels were quantified using enzyme-linked immunosorbent assay (ELISA) kits and examined at the time of diagnosis before receiving any treatment. Receiver operating characteristic (ROC) curves were used to determine the optimal VEGF cut-off value for predicting 6-month mortality. Associations between DLCO, serum VEGF levels, and 6-month mortality were analysed using Kaplan-Meier survival analysis and the Cox proportional hazards model.
Among 63 NSCLC patients, 74,6% had impaired diffusing capacity (34% mild, 44.7% moderate, 21.3% severe). ROC curve analysis identified a VEGF cut-off value of ≥1234.88 pg/ml associated with 6-month mortality (sensitivity 65.4%, specificity 64.9%, AUC 67.4%, p=0.02). Multivariate Cox proportional hazards analysis showed that lower DLCO was associated with increased 6-month mortality (HR=0.97, 95% CI: 0.95–0.99, p=0.009). High serum VEGF levels were also an independent predictor of 6-month mortality (HR=2.61, 95% CI: 1.16–5.87, p=0.02). Furthermore, spirometry revealed that 22 patients (34.4%) had COPD at the time of NSCLC diagnosis that was associated with significantly reduced survival compared to NSCLC patients without COPD (5.14 vs 5.5 months, p=0.01).
DLCO and high serum VEGF levels are independent predictors of 6-month mortality. Assessment of pulmonary function may improve early risk stratification and clinical management in patients with lung cancer.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Diffusing capacity of the lung for carbon monoxide, vascular endothelial growth factor, non-small cell lung cancer
maximum 3 keywords and no abbreviations, separated by commas
 
307